CBD's is known for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis.
ViaDerma sees the use of CBD's along with our Proprietary transdermal delivery system for the treatment and continuing studies looks very promising and demonstrates efficacy in terms of treating several unrelated diseases. "We are enthusiastic about the results we have achieved to date in terms of the anecdotal feedback we have received from the medical community," said Dr. Christopher Otiko, ViaDerma's founder and CEO.
VDRM is the great MARIJUANA pharmaceutical stock to own. Go VDRM
I see what the article states, but what Otiko said in the interview is something different regarding revenues. I hope there are sales of 500k units. It would be very significant for the share value by late 2017 or early 2018.